A common challenge for pharma is the high variability in measured outcome of drugs between clinical trials and real world use, especially in some of the costly chronic disease areas. With drug delivery data increasingly being digitized, opportunities arise to leverage IT to combine that data with other data sources (GPS, BGM/CGM, activity, nutrition, etc.), ultimately reducing the performance gaps between clinical trials and real world use. Leveraging IT goes well beyond “there is an app for this” as data needs to be collected, stored, analyzed and turned into meaningful insights for physicians, care teams and patients alike to improve the adherence. My Dose Coach is an IT solution for diabetes insulin dosing, collecting physicians’ data on titration schemes as well as the daily blood glucose and insulin data from patients to advise them according to their physican’s prescription. The solution includes a data backend, a patient app, and web access for physician and administrators to manage their clinic and patients. With an effective discussion occurring between physicians and patients, there is demand for additional data sources to be added in order to further enrich the dialogue as well as learning, allowing patients to make decisions based on these gained insights. Drug delivery efficacy is becoming an IT job requiring pharma companies to adopt new skills and capabilities in order to play in such a digital drug delivery world.

Leverage partneringONE® to identify and qualify technology leads and close the deal that expands your product lifecycle.

• Conduct more meetings at one conference than in the rest of the year
• Contact existing and potential partners prior to the conference
• Manage all your conference activities in one place
• Your meetings will be prescheduled to maximize your time on site.

Stanko Skrtic, MD, MBA, Associate Professor, Senior Science & Innovation Medical Director, Innovation Strategies
& External Liaison, AstraZeneca

Matt Huddleston, EVP and Chief Technical Officer, Enable Injections
Mark Destefano, Teva

More than 500 meetings expected in 2018.

Be sure to sign-up early for maximum partnering and exposure in 2018!